PreveCeutical Medical 

Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders. Other key initiatives involve the BSV Peptide Program, aimed at halting cancer progression; a non-addictive analgesic for effective pain management; and a Dual Gene Therapy addressing type 2 diabetes and obesity. Furthermore, PreveCeutical is developing a diverse array of medicinal products based on cannabis.